Kendrick Laboratories

Form 483 issued March 10, 2020 · Madison, Wisconsin

Inspection
Mar 9 – Mar 10, 2020
Observations
2
Pages
3
FEI number
3001238747

In short: On March 10, 2020, FDA issued a Form 483 with 2 observations to Kendrick Laboratories in Madison, Wisconsin (FEI 3001238747) after an inspection that ran Mar 9 – Mar 10, 2020. The investigators were Lori B. Wikstrom and Sandra A. Boyd. Most observations concern laboratory controls and quality system; the most-cited regulation is 21 CFR 211.160 (general requirements).

At a glance

Laboratory controls and quality system account for 2 of 2 observations.

Laboratory controls1
Quality system1

Most cited: 21 CFR 211.160(b) (1×) · 211.25(a) (1×)

What FDA observed

Preview: the opening words of each observation
  1. 01

    Laboratory controls do not include the establishment of scientifically sound and appropriate test procedures designed to…

  2. 02

    Employees are not given training in the particular operations they perform as…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Kendrick Laboratories?

FDA listed 2 observations on this Form 483, mostly about laboratory controls and quality system. The most-cited regulation is 21 CFR 211.160 (general requirements). The opening words of each observation are shown on this page.

Who inspected Kendrick Laboratories?

Lori B. Wikstrom and Sandra A. Boyd are named on this Form 483, for the inspection of Mar 9 – Mar 10, 2020. Each investigator has a profile showing what they cite most.

When was Kendrick Laboratories inspected by FDA?

The inspection ran Mar 9 – Mar 10, 2020, and the Form 483 is dated March 10, 2020.

How do I get the full Form 483 for Kendrick Laboratories?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free